A study to see the effect of local anaesthetic drug to decrease the pain after laparoscopic removal of uterus.
Not Applicable
Completed
- Conditions
- Health Condition 1: N924- Excessive bleeding in the premenopausal periodHealth Condition 2: D259- Leiomyoma of uterus, unspecified
- Registration Number
- CTRI/2021/10/037459
- Lead Sponsor
- AIIMS Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 154
Inclusion Criteria
1. Patients undergoing Laparoscopic Hysterectomy for benign conditions and for
premalignant lesions requiring simple TLH without additional procedures ( like
lymphnode dissection)
2. Patients consenting for the study.
Exclusion Criteria
1. TLH for Extensive Endometriosis.
2. TLH with Pelvic lymph nodal dissection in cases of Carcinoma Cervix, Carcinoma
Endometrium.
3. Uterus of size 14 weeks or higher.
4. Allergy to Bupivacaine.
5. Patients not giving consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in the VAS Score at 30 minutes and at 60 minutes after TLH in the subjects that received 0.5% Bupivacaine v/s those who <br/ ><br>received Placebo.Timepoint: 30 minutes and at 60 minutes
- Secondary Outcome Measures
Name Time Method Duration of hospital stayTimepoint: 48 hours